As of May 23
| +0.51 / +0.80%|
The 22 analysts offering 12-month price forecasts for Merck have a median target of 70.00, with a high estimate of 90.00 and a low estimate of 51.00. The median estimate represents a +8.44% increase from the last price of 64.55.
The current consensus among 24 polled investment analysts is to Buy stock in Merck. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.